The Oncology Institute(TOI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TOI The Oncology Institute

Trading 04-23 12:49:21 EDT

3.28

-0.16

-4.67%

High3.43	Low3.26	Vol468.31K
Open3.41	D1 Closing3.44	Amplitude5.09%
Mkt Cap322.62M	Tradable Cap270.34M	Total Shares98.38M
T/O1.54M	T/O Rate0.57%	Tradable Shares82.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TOI","market":"US","secType":"STK","nameCN":"The Oncology Institute","latestPrice":3.2793,"timestamp":1776962956029,"preClose":3.44,"halted":0,"volume":468307,"delay":0,"changeRate":-0.04671511627906972,"floatShares":82439500,"shares":98381340,"eps":-0.544488,"marketStatus":"Trading","change":-0.1607,"latestTime":"04-23 12:49:21 EDT","open":3.41,"high":3.43,"low":3.255,"amount":1540605.7413222,"amplitude":0.050872,"askPrice":3.28,"askSize":618,"bidPrice":3.27,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-0.544488,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1776974400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":3.44,"preHourTrading":{"tag":"盘前","latestPrice":3.4,"preClose":3.44,"latestTime":"09:05 EDT","volume":1,"amount":3.4,"timestamp":1776949523254,"change":-0.04,"changeRate":-0.011628,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.46,"preClose":3.44,"latestTime":"19:59 EDT","volume":9570,"amount":32925.54,"timestamp":1776902369223,"change":0.02,"changeRate":0.005814,"amplitude":0.005814},"volumeRatio":0.582691,"impliedVol":1.0565,"impliedVolPercentile":0.5873},"requestUrl":"/m/hq/s/TOI","defaultTab":"news","newsList":[{"id":"2628247400","title":"Oncology Institute director Mohit Kaushal disposes 95,719 shares worth $335,087","url":"https://stock-news.laohu8.com/highlight/detail?id=2628247400","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628247400?lang=en_us&edition=fundamental","pubTime":"2026-04-17 07:28","pubTimestamp":1776382086,"startTime":"0","endTime":"0","summary":"Oncology Institute director Mohit Kaushal sold 95,719 common shares in transactions dated April 14 and April 16.Disposition was made under a Rule 10b5-1 trading plan adopted Dec. 16, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL1Jkv9f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Oncology Institute director Mohit Kaushal disposes 95,719 shares worth $335,087","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627493966","title":"Major Investor Quietly Ups Bet on The Oncology Institute in Latest Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2627493966","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627493966?lang=en_us&edition=fundamental","pubTime":"2026-04-14 10:01","pubTimestamp":1776132095,"startTime":"0","endTime":"0","summary":"New insider activity at Oncology Institute ( ($TOI) ) has taken place on April 13, 2026. Significant shareholder Chernett Jorey has increased their...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-ups-bet-on-the-oncology-institute-in-latest-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-ups-bet-on-the-oncology-institute-in-latest-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627555184","title":"Oncology Institute posts USD 1.8 million Medicare savings in CMS Enhancing Oncology Model period 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2627555184","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627555184?lang=en_us&edition=fundamental","pubTime":"2026-04-13 21:05","pubTimestamp":1776085510,"startTime":"0","endTime":"0","summary":"Oncology Institute posted USD 1.8 million in Medicare savings in CMS Enhancing Oncology Model Performance Period 3, equal to more than USD 6,400 per patient episode.Savings rose 63.6% from Performance Period 2, when results totaled USD 1.1 million, or more than USD 3,500 per episode.Quality performance included a second straight period with maximum scores on avoidable emergency department visits and hospital admissions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL6Jt2lf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","TOI","SG9999014021.USD","IE00B64PRP62.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","BK4588","LU2210149790.SGD","NDAQ","SG9999014005.SGD","SG9999014039.USD","IE00BN0W2W23.USD","BK4585","SG9999014013.SGD","BK4185","LU2210150020.SGD","IE00BGHQF748.EUR","BK4112","LU2095319765.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627455349","title":"Oncology Institute 10% owner Jorey Chernett buys 20,000 shares for $62,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2627455349","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627455349?lang=en_us&edition=fundamental","pubTime":"2026-04-13 21:04","pubTimestamp":1776085461,"startTime":"0","endTime":"0","summary":"Jorey Chernett, 10% owner of Oncology Institute, reported purchase of 20,000 common shares at $3.1 per share.Chernett reported direct ownership of 10,499,358 Oncology Institute shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDLcclFJD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Oncology Institute 10% owner Jorey Chernett buys 20,000 shares for $62,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626218721","title":"Oncology Institute CEO, CFO to speak at Needham Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2626218721","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626218721?lang=en_us&edition=fundamental","pubTime":"2026-04-09 21:06","pubTimestamp":1775739985,"startTime":"0","endTime":"0","summary":"The Oncology Institute executives will participate in 25th Annual Needham Healthcare Conference on April 15, 2026.CEO Daniel Virnich will join CFO Rob Carter for a fireside chat at 3:45 p.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL2zrmXv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","NDAQ","IE00B3QW5Z07.USD","SG9999014039.USD","IE00BN0W2V16.EUR","LU0314104364.USD","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SG9999014021.USD","BK4585","IE00BKPKM429.USD","TOI","SG9999014013.SGD","LU2210150020.SGD","LU2095319765.USD","BK4185","BK4112","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625066671","title":"Press Release: The Oncology Institute Names Minh Merchant Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2625066671","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625066671?lang=en_us&edition=fundamental","pubTime":"2026-04-06 21:00","pubTimestamp":1775480400,"startTime":"0","endTime":"0","summary":"CERRITOS, Calif., April 06, 2026  -- The Oncology Institute, Inc.  , one of the largest value-based oncology groups in the United States, today announced that Minh Merchant has joined the organization as Chief Legal Officer. In this role, Ms. Merchant will oversee legal, regulatory, compliance and privacy functions as TOI continues to scale. This role will be essential in enabling the company to continue its growth trajectory while further enhancing its mission to be a trusted healthcare partner to oncology patients and payors.Founded in 2007, The Oncology Institute  is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 cli","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623501345","title":"Oncology Institute 10% owner Jorey Chernett acquires $0.08 million common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2623501345","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623501345?lang=en_us&edition=fundamental","pubTime":"2026-03-30 21:39","pubTimestamp":1774877951,"startTime":"0","endTime":"0","summary":"Oncology Institute 10% owner Jorey Chernett reported a purchase of 27,429 common shares at USD 2.96.Chernett’s direct holding rose to 10,479,358 shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL7KcLfL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Oncology Institute 10% owner Jorey Chernett acquires $0.08 million common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622802653","title":"Major Investor Quietly Boosts Position in The Oncology Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2622802653","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622802653?lang=en_us&edition=fundamental","pubTime":"2026-03-28 10:02","pubTimestamp":1774663374,"startTime":"0","endTime":"0","summary":"New insider activity at Oncology Institute ( ($TOI) ) has taken place on March 27, 2026. Significant shareholder Chernett Jorey has increased their...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-position-in-the-oncology-institute-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-position-in-the-oncology-institute-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622822212","title":"Jorey Chernett, 10% owner; acquires The Oncology Institute common shares valued at $158,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2622822212","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622822212?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:37","pubTimestamp":1774618651,"startTime":"0","endTime":"0","summary":"Jorey Chernett, a 10% owner of Oncology Institute, reported a purchase of 50,000 common shares.The shares were acquired at a weighted average price of USD 3.15 per share.Following the reported transaction, Chernett beneficially owned 10,451,929 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL8PSZKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Jorey Chernett, 10% owner; acquires The Oncology Institute common shares valued at $158,000","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622071392","title":"Jorey Chernett; acquires 125,000 The Oncology Institute common shares valued at $388,750","url":"https://stock-news.laohu8.com/highlight/detail?id=2622071392","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622071392?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:33","pubTimestamp":1774445626,"startTime":"0","endTime":"0","summary":"Jorey Chernett, a 10% owner of The Oncology Institute, acquired 125,000 shares of Common Stock in an open-market purchase.Ownership of Common Stock increases to 10.4 million shares following the transaction.The purchase price is listed at $3.11 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 25, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL61Kj8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Jorey Chernett; acquires 125,000 The Oncology Institute common shares valued at $388,750","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621435034","title":"Major Investor Quietly Boosts Stake in The Oncology Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2621435034","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621435034?lang=en_us&edition=fundamental","pubTime":"2026-03-24 10:06","pubTimestamp":1774317974,"startTime":"0","endTime":"0","summary":"New insider activity at Oncology Institute ( ($TOI) ) has taken place on March 23, 2026. Significant shareholder Chernett Jorey has expanded their ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-stake-in-the-oncology-institute-insider-trading-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-stake-in-the-oncology-institute-insider-trading-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621709198","title":"10% owner Jorey Chernett acquires USD 83,750 of The Oncology Institute common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2621709198","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621709198?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:33","pubTimestamp":1774272825,"startTime":"0","endTime":"0","summary":"Jorey Chernett, a 10% owner of Oncology Institute, reported buying 25,000 common shares.The reported weighted average purchase price was USD 3.35 per share.Following the transaction, Chernett reported beneficial ownership of 10,276,929 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL9nRYZd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"10% owner Jorey Chernett acquires USD 83,750 of The Oncology Institute common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621075178","title":"The Oncology Institute files initial beneficial ownership statement for director Kimberly Jo Tzoumakas","url":"https://stock-news.laohu8.com/highlight/detail?id=2621075178","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621075178?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:34","pubTimestamp":1774038882,"startTime":"0","endTime":"0","summary":"Oncology Institute director Kimberly Tzoumakas filed a Form 3 initial statement of beneficial ownership covering an event dated Feb. 23, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL2YvrhZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620288410","title":"Major Investor Quietly Boosts Stake in The Oncology Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2620288410","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620288410?lang=en_us&edition=fundamental","pubTime":"2026-03-18 10:06","pubTimestamp":1773799578,"startTime":"0","endTime":"0","summary":"New insider activity at Oncology Institute ( ($TOI) ) has taken place on March 17, 2026. Significant shareholder Chernett Jorey has expanded their ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-stake-in-the-oncology-institute-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-stake-in-the-oncology-institute-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620014734","title":"The Oncology Institute 10% owner Jorey Chernett acquires USD 1.13 million in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620014734","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620014734?lang=en_us&edition=fundamental","pubTime":"2026-03-18 07:40","pubTimestamp":1773790841,"startTime":"0","endTime":"0","summary":"Jorey Chernett, a 10% owner of Oncology Institute, reported purchases of 398,985 common shares. The reported purchase prices were USD 2.92 per share and USD 3.42 per share. Following the transactions, Chernett beneficially owned 10,251,929 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL95Cv2b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"The Oncology Institute 10% owner Jorey Chernett acquires USD 1.13 million in common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619468259","title":"The Oncology Institute Inc. files Form 3 initial beneficial ownership statement for Jorey Chernett","url":"https://stock-news.laohu8.com/highlight/detail?id=2619468259","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619468259?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:32","pubTimestamp":1773664366,"startTime":"0","endTime":"0","summary":"Jorey Chernett filed a Form 3 initial beneficial ownership statement for Oncology Institute, trading symbol TOI. The filing reported direct ownership of 9,852,944 shares of common stock with $0.0001 par value. Chernett was listed as a 10% owner, and the event date requiring the statement was 03/13/2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDLbdsc4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619818146","title":"Oncology Institute (TOI) Q4 Loss Per Share Improvement Tests Longstanding Profitability Doubts","url":"https://stock-news.laohu8.com/highlight/detail?id=2619818146","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619818146?lang=en_us&edition=fundamental","pubTime":"2026-03-14 06:24","pubTimestamp":1773440657,"startTime":"0","endTime":"0","summary":"Oncology Institute (TOI) closed out FY 2025 with Q4 revenue of US$142.0 million and a basic EPS loss of US$0.07, while trailing twelve month figures show revenue of US$502.7 million and a net loss of US$60.6 million. The company has seen quarterly revenue move from US$100.3 million in Q4 2024 to US$142.0 million in Q4 2025, with basic EPS losses ranging from US$0.21 in Q1 2025 to US$0.07 in Q4, presenting a picture in which top line scale is increasing while margins remain clearly...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-toi/oncology-institute/news/oncology-institute-toi-q4-loss-per-share-improvement-tests-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-toi/oncology-institute/news/oncology-institute-toi-q4-loss-per-share-improvement-tests-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619194187","title":"B. Riley Adjusts Price Target on Oncology Institute to $8 From $6, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194187","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194187?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:59","pubTimestamp":1773403191,"startTime":"0","endTime":"0","summary":"B. Riley Adjusts Price Target on Oncology Institute to $8 From $6, Maintains Buy Rating","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619219165","title":"Oncology Institute Price Target Maintained With a $5.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2619219165","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619219165?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:31","pubTimestamp":1773401460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TOI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2026 07:31 ET (11:31 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619193990","title":"Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2619193990","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619193990?lang=en_us&edition=fundamental","pubTime":"2026-03-13 17:41","pubTimestamp":1773394860,"startTime":"0","endTime":"0","summary":"The Oncology Institute (TOI) stock rose in pre-market trading after reporting better-than-expected financial results. Other gainers include ISPC, PAYP, and EONR.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/13/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/13/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/26/03/51234968/why-oncology-institute-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/26/03/51234968/why-oncology-institute-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4185","TOI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.theoncologyinstitute.com","stockEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.0717},{"period":"3month","weight":-0.0418},{"period":"6month","weight":-0.2758},{"period":"1year","weight":0.2694},{"period":"ytd","weight":-0.0337}],"compareEarnings":[{"period":"1week","weight":0.0161},{"period":"1month","weight":0.0852},{"period":"3month","weight":0.0323},{"period":"6month","weight":0.0501},{"period":"1year","weight":0.3489},{"period":"ytd","weight":0.043}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.260474},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.061864},{"month":3,"riseRate":0.5,"avgChangeRate":-0.006328},{"month":4,"riseRate":0.666667,"avgChangeRate":0.139937},{"month":5,"riseRate":0.4,"avgChangeRate":-0.057716},{"month":6,"riseRate":0.5,"avgChangeRate":-0.094312},{"month":7,"riseRate":0.833333,"avgChangeRate":0.340043},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.040327},{"month":9,"riseRate":0.5,"avgChangeRate":-0.018468},{"month":10,"riseRate":0.5,"avgChangeRate":0.091691},{"month":11,"riseRate":0,"avgChangeRate":-0.319754},{"month":12,"riseRate":1,"avgChangeRate":0.32933}],"exchange":"NASDAQ","name":"The Oncology Institute","nameEN":"The Oncology Institute"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"The Oncology Institute(TOI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest The Oncology Institute(TOI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"The Oncology Institute,TOI,The Oncology Institute股票,The Oncology Institute股票老虎,The Oncology Institute股票老虎国际,The Oncology Institute行情,The Oncology Institute股票行情,The Oncology Institute股价,The Oncology Institute股市,The Oncology Institute股票价格,The Oncology Institute股票交易,The Oncology Institute股票购买,The Oncology Institute股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"The Oncology Institute(TOI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest The Oncology Institute(TOI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction